AzTrials
AzTrials

Spinal FusionNCT03692845

Minimally Invasive Versus Open Transforaminal Lumbar Interbody Fusion

A study testing Transforaminal Lumbar Interbody Fusion either open or minimally invasive in people with Spinal Fusion, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A study that compares between Open TLIF and Minimally invasive TLIF regarding patients' functional status(Oswestry Disability index)as a primary outcome measure. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Spinal Fusion
What is being tested?
Transforaminal Lumbar Interbody Fusion either open or minimally invasive
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
Nov 2018to Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults more than 18 years of age and less than 65 years of age..
  • Degenerative or isthmic spondylolithesis Grade 1,2 and 3.
  • Recurrent Symptomatic recurrent lumbar disc prolapsed with or without evident neural compression.
  • Single level pathology involving L2-3, L3-4, L4-5 and or L5-S1.
  • Symptoms not responding to conservative treatment for at least 3 months.

Who cannot join

  • Previous spinal fusion or instrumentation.
  • Spinal tumours, infection and fractures.
  • Patients with severe osteoporosis
  • BMI more than 35.
  • Non-ambulant patients and patients with severe preoperative neurological affection (Cauda Equina Syndrome)
  • Patients not willing to participate in the study

About this study

A study that compares between Open TLIF and Minimally invasive TLIF regarding patients' functional status(Oswestry Disability index)as a primary outcome measure.

Read the detailed description

The first randomized controlled trial comparing minimally invasive TLIF and open TLIF.

Conditions
Spinal Fusion
Being tested
Transforaminal Lumbar Interbody Fusion either open or minimally invasive
Keywords
spine fusion, minimally invasive surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transforaminal Lumbar Interbody Fusion either open or minimally invasiveProcedure or surgery

    Spinal fusion procedure through the intervertebral foramen

Study groups in NCT03692845
Study groupRoleWhat they receive
O-TLIF groupOtherSpinal fusion ,Transforaminal lumbar interbody fusion procedure will be performed through open surgery.
Receives: Procedure: Transforaminal Lumbar Interbody Fusion either open or minimally invasive
MI-TLIF groupOtherSpinal fusion,Transforaminal lumbar interbody fusion procedure will be performed through minimally invasive surgery using a tubular retractor.
Receives: Procedure: Transforaminal Lumbar Interbody Fusion either open or minimally invasive

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oswestry Disability index(Arabic version) 1 month

    an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.

    Measured: 1 month

Secondary outcomes (1)
  1. • Fusion rate as assessed by Bridwell fusion score.

    Grade I is defined as fusion with remodelling and trabeculae present; Grade II is an intact graft with incomplete remodelling and no lucency present; Grade III is an intact graft with potential lucency at the cranial or caudal end; Grade IV is absent fusion with collapse/resorption of the graft.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2018
  2. Study startNov 2018 (estimated)
  3. Primary completionNov 2020 (estimated)
  4. Study completionOct 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03692845
Sponsor's protocol ID
6272829
Status last verified
Sep 2018
First submitted
28 Sep 2018
Last updated
2 Oct 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Transforaminal Lumbar Interbody Fusion either open or minimally invasive in people with Spinal Fusion, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oswestry Disability index(Arabic version) 1 month (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in